An Efficacy and Outcome Study of Supplemental Oxygen Treatment in Patients With Suspected Myocardial Infarction
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 6629 participants.
Also called NCT01787110
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 6,629 participants
- Registry
-
NCT01787110
-
- Other papers using this trial's data
- Avoiding Routine Oxygen Therapy in Patients With Myocardial Infarction Saves Significant Expenditure for the Health Care System-Insights From the Randomized DETO2X-AMI Trial
- Effect of Oxygen Therapy on Cardiovascular Outcomes in Relation to Baseline Oxygen Saturation
- Long-Term Effects of Oxygen Therapy on Death or Hospitalization for Heart Failure in Patients With Suspected Acute Myocardial Infarction
- Oxygen Therapy in Suspected Acute Myocardial Infarction
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Sweden
- Registry status
- Completed
Technical summary
Registry record NCT01787110. Randomized; no masking; primary purpose treatment. Start 2013-04 (actual); primary completion 2016-12-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- An Efficacy and Outcome Study of Supplemental Oxygen Treatment in Patients With Suspected Myocardial Infarction
- Acronym
- DETO2X-AMI
- Condition
- Acute Coronary Syndrome
- Condition
- Non-ST Elevation (NSTEMI) Myocardial Infarction
- Condition
- Acute ST Segment Elevation Myocardial Infarction
- Condition
- Angina, Unstable
- Intervention (Drug)
- Oxygen
- Lead sponsor
- Karolinska Institutet
- Collaborator
- Swedish Heart Lung Foundation
- Collaborator
- Swedish Foundation for Strategic Research
- Collaborator
- The Swedish Research Council
Record details
- Record id
cardio:ct-nct01787110- Content hash
0c8840c03d33569a58ef123dcb6522c734213da67cb20e00c25459d446bc4c73